Markets:

Overview

News

Currencies

International

Treasuries

Amylyx Pharmaceuticals, Inc. - Common Stock (NQ:AMLX)

32.09 -0.31 (-0.96%)

Streaming Delayed Price Updated: 4:00 PM EDT, Sep 10, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Amylyx Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

7 Healthcare Stocks Taking Medicine to the Next Level ↗

January 14, 2024

With advances in technology potentially able to improve the human condition, these are the compelling healthcare stocks to consider.

Via InvestorPlace

2 Biotech Stocks With Huge Catalysts in 2024 ↗

January 05, 2024

Important clinical-trial readouts on the way could send these stocks soaring in early 2024.

Via The Motley Fool

3 Top-Rated Biotech Stocks That Analysts Are Loving Now ↗

November 28, 2023

Investing in biotech stocks can be tricky, but analysts have bullish outlooks on these three, promising companies.

Via InvestorPlace

Amylyx Crashes 26% As New ALS Drug Faces A Barrage Of Troubles ↗

November 09, 2023

The company says patient discontinuations mounted in the quarter.

Via Investor's Business Daily

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

November 09, 2023

Via Benzinga

Earnings Preview For Amylyx Pharma ↗

November 08, 2023

Via Benzinga

Expert Ratings for Amylyx Pharma ↗

August 11, 2023

Via Benzinga

A Preview Of Amylyx Pharma's Earnings ↗

August 09, 2023

Via Benzinga

Why Shares of Amylyx Pharmaceuticals Were Up Monday ↗

July 24, 2023

The company got a bump from an analyst's upgrade.

Via The Motley Fool

Why AMC Entertainment Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

November 09, 2023

Gainers Intelligent Bio Solutions Inc. (NASDAQ: INBS) shares climbed 83.5% to $0.4169 after reporting first-quarter results.

Via Benzinga

3 Under-the-Radar Biotech Stocks to Buy in 2023 ↗

October 19, 2023

These three lesser-known biotech companies are profitable and growing revenue.

Via The Motley Fool

4 Analysts Have This to Say About Amylyx Pharma ↗

July 24, 2023

Via Benzinga

7 Analysts Have This to Say About Amylyx Pharma ↗

May 31, 2023

Via Benzinga

What 7 Analyst Ratings Have To Say About Amylyx Pharma ↗

May 15, 2023

Via Benzinga

Analyst Expectations for Amylyx Pharma's Future ↗

May 15, 2023

Via Benzinga

Amylyx Pharma Earnings Preview ↗

May 10, 2023

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

October 18, 2023

Via Benzinga

2 Incredible Growth Stocks Near 52-Week Lows to Buy Now ↗

October 10, 2023

These two high-tech bio companies may be too cheap to ignore right now.

Via The Motley Fool

3 Up-and-Coming Biotech Stocks to Put on Your Must-Buy List ↗

August 28, 2023

Here are some intriguing up-and-coming biotech stocks that may reward risk-tolerant investors with a long-term outlook.

Via InvestorPlace

3 Biotech Stocks to Buy Before Drug Trials End ↗

July 28, 2023

Drug trials are a chance for high risk, high reward investing. These stocks doing neurodegenerative trials could be set for big gains.

Via InvestorPlace

Amylyx Stock Has A Good Entry Point, Says Bullish Goldman Sachs ↗

July 24, 2023

Shares of Amylyx Pharmaceuticals Inc (NASDAQ: AMLX) jumped in early trading on Monday, after remaining broadly flat last week.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 24, 2023 ↗

July 24, 2023

Via Benzinga

EMA's Advisory Panel Gives Thumbs Down To Amylyx Pharma's Amyotrophic Lateral Sclerosis Treatment ↗

June 23, 2023

The European Medicines Agency's Committee for Medicinal Products for Human Use has adopted a negative opinion regarding Amylyx Pharmaceuticals Inc's (NASDAQ: AMLX) conditional marketing authorization...

Via Benzinga

Better Growth Stock: Amylyx Pharmaceuticals or Viking Therapeutics? ↗

June 13, 2023

Which of these red-hot biotech stocks is the better buy right now?

Via The Motley Fool

How Biohaven Is Coming 'Out Of Stealth Mode' — And Bullishly Extending A 4-Day Run ↗

June 01, 2023

Shares surged into and out of the company's R&D Day, which included a surprise.

Via Investor's Business Daily

2 Supercharged Growth Stocks to Buy Right Now ↗

May 14, 2023

These two biopharma stocks might be poised for a major breakout.

Via The Motley Fool

10 Health Care Stocks With Whale Alerts In Today's Session ↗

May 12, 2023

Via Benzinga

US Stock Futures Signal Strong Finish To Wobbly Week — But Analyst Still Sees Recession Risk On Horizon ↗

May 12, 2023

Via Benzinga

Amylyx Blows Past Sales Expectations, Reports Unexpected Profit — Shares Rocket ↗

May 11, 2023

The company was expected to post another loss, but instead came in with a gain of 2 cents per share.

Via Investor's Business Daily

3 Biotechs That Might Get Bought Out in 2023 ↗

April 26, 2023

Biotech is expected to be a hotbed of mergers and acquisitions this year.

Via The Motley Fool

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Amylyx Pharmaceuticals, Inc. - Common Stock (NQ:AMLX)

Headline News about Amylyx Pharmaceuticals, Inc. - Common Stock

Starting at /week.